Xylem Historical Balance Sheet
XYL Stock | USD 130.89 2.11 1.64% |
Trend analysis of Xylem Inc balance sheet accounts such as Common Stock Shares Outstanding of 203.7 M, Total Assets of 19.5 B, Other Current Liabilities of 1.1 B or Total Current Liabilities of 1.3 B provides information on Xylem's total assets, liabilities, and equity, which is the actual value of Xylem Inc to its prevalent stockholders. By breaking down trends over time using Xylem balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Xylem Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xylem Inc is a good buy for the upcoming year.
Xylem Inventory |
|
Xylem |
About Xylem Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Xylem Inc at a specified time, usually calculated after every quarter, six months, or one year. Xylem Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Xylem and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Xylem currently owns. An asset can also be divided into two categories, current and non-current.
Xylem Balance Sheet Chart
Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Xylem assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Xylem Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Xylem balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Xylem Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Xylem's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Xylem Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. At this time, Xylem's Non Current Assets Total are quite stable compared to the past year. Other Assets is expected to rise to about 798.2 M this year, although the value of Total Current Liabilities will most likely fall to about 1.3 B.
2022 | 2023 | 2024 | 2025 (projected) | Other Current Liabilities | 612M | 945M | 1.1B | 1.1B | Total Assets | 8.0B | 16.1B | 18.5B | 19.5B |
Xylem balance sheet Correlations
Click cells to compare fundamentals
Xylem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xylem balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Common Stock Shares Outstanding | 181.1M | 181.5M | 181.0M | 218.2M | 250.9M | 203.7M | |
Total Assets | 8.8B | 8.3B | 8.0B | 16.1B | 18.5B | 19.5B | |
Other Current Liab | 670M | 683M | 612M | 945M | 1.1B | 1.1B | |
Total Current Liabilities | 2.0B | 1.4B | 1.6B | 2.2B | 2.5B | 1.3B | |
Total Stockholder Equity | 3.0B | 3.2B | 3.5B | 10.2B | 11.7B | 12.3B | |
Other Liab | 1.0B | 1.3B | 1.2B | 730M | 839.5M | 787.3M | |
Property Plant And Equipment Net | 657M | 644M | 630M | 1.5B | 1.7B | 1.8B | |
Net Debt | 1.2B | 1.1B | 1.0B | 1.4B | 1.6B | 1.1B | |
Accounts Payable | 569M | 639M | 723M | 968M | 1.1B | 1.2B | |
Cash | 1.9B | 1.3B | 944M | 1.0B | 1.2B | 721.5M | |
Non Current Assets Total | 5.2B | 5.1B | 4.9B | 12.2B | 14.1B | 14.8B | |
Non Currrent Assets Other | 623M | 664M | 360M | 415M | 477.3M | 325.2M | |
Other Assets | 348M | 623M | 664M | 661M | 760.2M | 798.2M | |
Cash And Short Term Investments | 1.9B | 1.3B | 944M | 1.0B | 1.2B | 721.5M | |
Net Receivables | 923M | 953M | 1.1B | 1.6B | 1.9B | 998.3M | |
Good Will | 2.9B | 2.8B | 2.7B | 7.6B | 8.7B | 9.2B | |
Liabilities And Stockholders Equity | 8.8B | 8.3B | 8.0B | 16.1B | 18.5B | 19.5B | |
Non Current Liabilities Total | 3.8B | 3.7B | 2.9B | 3.7B | 4.3B | 2.7B | |
Inventory | 558M | 700M | 799M | 1.0B | 1.2B | 601.9M | |
Other Current Assets | 167M | 158M | 173M | 230M | 264.5M | 159.6M | |
Total Liab | 5.8B | 5.1B | 4.4B | 5.9B | 6.8B | 4.0B | |
Property Plant And Equipment Gross | 657M | 1.8B | 1.8B | 2.5B | 2.8B | 3.0B | |
Total Current Assets | 3.5B | 3.2B | 3.0B | 3.9B | 4.5B | 2.5B | |
Accumulated Other Comprehensive Income | (413M) | (371M) | (226M) | (269M) | (242.1M) | (230.0M) | |
Intangible Assets | 1.1B | 1.0B | 930M | 2.5B | 2.9B | 3.1B | |
Property Plant Equipment | 658M | 657M | 644M | 630M | 724.5M | 599.5M | |
Short Long Term Debt Total | 3.1B | 2.5B | 1.9B | 2.4B | 2.7B | 2.2B | |
Net Tangible Assets | (1.1B) | (979M) | (590M) | (155M) | (139.5M) | (146.5M) | |
Noncontrolling Interest In Consolidated Entity | 14M | 10M | 8M | 9M | 10.4M | 7.5M | |
Retained Earnings | 1.9B | 2.2B | 2.3B | 2.6B | 3.0B | 3.1B | |
Long Term Debt | 2.5B | 2.4B | 1.9B | 2.3B | 2.6B | 2.0B | |
Retained Earnings Total Equity | 1.9B | 1.9B | 2.2B | 2.3B | 2.6B | 1.3B | |
Long Term Debt Total | 2.0B | 2.5B | 2.4B | 1.9B | 2.2B | 1.9B | |
Capital Surpluse | 2.0B | 2.0B | 2.1B | 2.1B | 2.5B | 2.1B | |
Other Stockholder Equity | 1.4B | 1.4B | 1.4B | 7.8B | 9.0B | 9.5B | |
Deferred Long Term Liab | 310M | 242M | 287M | 222M | 255.3M | 254.2M | |
Treasury Stock | (527M) | (588M) | (656M) | (708M) | (637.2M) | (605.3M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.211 | Dividend Share 1.44 | Earnings Share 3.65 | Revenue Per Share | Quarterly Revenue Growth 0.065 |
The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.